Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Effects of the genome on immune regulation in type 1 diabetes
Flemming Pociot
,
Simranjeet Kaur
, Lotte B Nielsen
Department of Clinical Medicine
7
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Effects of the genome on immune regulation in type 1 diabetes'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Biochemistry, Genetics and Molecular Biology
Genotyping
100%
Immunoregulation
100%
Genetic Divergence
66%
Genetics
66%
Chemokine
33%
Chromosome 6
33%
Human Leukocyte Antigen
33%
Major Histocompatibility Complex
33%
CCL4
33%
Single-Nucleotide Polymorphism
33%
Chromosome 3
33%
Genetic Variation
33%
Chromosome 2
33%
Genetic Susceptibility
33%
CCL2
33%
Immunity
33%
Amino Acid
33%
Autoantibody
33%
Keyphrases
Immune Regulation
100%
Type I Diabetes
100%
Type 1 Diabetes Mellitus (T1DM)
100%
Immunochip
42%
Disease Risk
14%
DRB1
14%
Langerhans Islets
14%
Chromosome 3
14%
Genetic Variation
14%
Immune Response
14%
Fine Mapping
14%
Genetic Susceptibility Factors
14%
Carbon Tetrachloride
14%
HLA-DQB1
14%
Autoantibodies
14%
Genetic Disease
14%
Insulin-producing Cells
14%
Chemokines
14%
Genetic Contribution
14%
Genetic Studies
14%
Chemokine (C-C motif) Ligand 2 (CCL2)
14%
Recent-onset
14%
Amino Acid Residues
14%
Genetic Variants
14%
Human Leukocyte Antigen
14%
Chromosome 6
14%
Complex Disease
14%
Major Histocompatibility Complex
14%
Single nucleotide Polymorphism (SNP) Genotyping
14%
Circulating Levels
14%
Functional Significance
14%
Environmental Factors
14%
Chromosome 2
14%
Immunology and Microbiology
Immunoregulation
100%
Single Nucleotide Polymorphism
50%
Chromosome 6
50%
Chromosome 3
50%
Insulin
50%
Major Histocompatibility Complex
50%
Chemokine
50%
Amino Acid
50%
Immunity
50%
CCL2
50%
Genetic Susceptibility
50%
Autoantibody
50%
Human Leukocyte Antigen
50%
Genetic Variation
50%